Skip to main content

VitaCholine`s Happy Heart and Brain Power products named finalist for The NutraIngredients Awards Finished product of the year!

News   •  Apr 13, 2015 13:54 GMT, a key news source for the functional food & beverage and dietary supplement industries, has named VanEeghen,Ayanda’s partner in the VitaCholine softdrop product line, as a finalist for its NutraIngredients Awards (NIA), in the Finished Product of the Year in the Heart & Brain category. The NIA will be given out during Vitafoods Europe on May 6 in Geneva at the Starling Geneva Hotel & Conference Center in Switzerland. Both Happy Heart and Brain Power are supported with several EFSA claims, making them attractive and easy to market.

Happy Heart

Brain Power

We are honored to be recognized for our ongoing efforts to deliver true innovation and cutting edge research by, and to be acknowledged with these other prestigious companies.

Our production practices center around our commitment to manufacturing using state of the art production facilities, and ensuring that our ingredients offer fresh and pure solutions.  

With innovation a huge focus in our products, we are pleased to find that our partnership with VanEeghen for the VitaCholine product line is giving us attention in Europe, and that our Happy Heart and Brain Power products have received this nomination. We are proud to see The VitaCholine product line has met the NIA requirement for entry, demonstrably protecting and optimizing heart and/or brain health in a way that sets it apart in a competitive market segment.     

The VitaCholine product line came about as a result of the partnership between the ingredient supplier VanEeghen and Ayanda, the delivery form specialist. It consists of 5 turnkey products, where 5 popular and distinct health areas are addressed. All products contain the essential nutrient VitaCholine, produced with superior quality. The benefits have been documented through studies, FDA findings and EFSA authorized claims.

Read more about the product line here.

Comments (0)

Add comment